Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

MegaPro Biomedical Co., Ltd. (6827) Financial Statements

MegaPro Biomedical Co., Ltd. Financial Overview

MegaPro Biomedical Co., Ltd.'s market cap is currently NT$1.21B. The company's EPS TTM is NT$-1.30; its P/E ratio is -12.38; MegaPro Biomedical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 0.00NT$ 14.00KNT$ 18.00KNT$ 0.00NT$ 0.00
Gross ProfitNT$ 0.00NT$ -17.19MNT$ -16.60MNT$ -13.56MNT$ -7.54M
Operating IncomeNT$ -119.59MNT$ -180.19MNT$ -140.49MNT$ -121.75MNT$ -100.97M
EBITDANT$ -103.91MNT$ -146.38MNT$ -110.34MNT$ -97.36MNT$ -81.61M
Net IncomeNT$ -119.10MNT$ -164.04MNT$ -127.55MNT$ -111.72MNT$ -89.15M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 112.28MNT$ 87.68MNT$ 187.88MNT$ 144.22MNT$ 351.71M
Total AssetsNT$ 278.92MNT$ 224.31MNT$ 294.58MNT$ 342.68MNT$ 432.61M
Total DebtNT$ 2.88MNT$ 5.65MNT$ 8.32MNT$ 10.93MNT$ 13.46M
Net DebtNT$ -109.41MNT$ -82.02MNT$ -179.56MNT$ -133.30MNT$ -154.24M
Total LiabilitiesNT$ 16.28MNT$ 19.96MNT$ 25.51MNT$ 28.34MNT$ 26.77M
Stockholders' EquityNT$ 262.64MNT$ 204.35MNT$ 269.07MNT$ 314.35MNT$ 405.84M
Cash Flow
Free Cash FlowNT$ -116.78MNT$ -145.34MNT$ -104.09MNT$ -96.30MNT$ -102.94M
Operating Cash FlowNT$ -115.89MNT$ -144.17MNT$ -99.70MNT$ -82.80MNT$ -85.03M
Investing Cash FlowNT$ -37.15MNT$ 23.81MNT$ 18.78MNT$ 56.41MNT$ -85.29M
Financing Cash FlowNT$ 177.23MNT$ 81.84MNT$ 62.86MNT$ -2.51MNT$ 245.00M

Currency in TWD

MegaPro Biomedical Co., Ltd. Earnings and Revenue History

-200M-100M0100M-1500000 %-1000000 %-500000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

MegaPro Biomedical Co., Ltd. Liabilities to Assets

0200M400M600M4 %6 %8 %10 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

MegaPro Biomedical Co., Ltd. Cash Flow

-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

MegaPro Biomedical Co., Ltd. Forecast EPS vs Actual EPS

Earnings >